Mosaic ImmunoEngineering CPMV Growth Metrics (2010-2026)

OTC CPMV
$0.06 +0.00 (+0.00%)
As of: Oct 21, 2026 · 11:47 AM EDT
Reported Financials

Mosaic ImmunoEngineering Quarterly Growth Metrics

Periods 61 quarters
Latest Mar 2026

Mosaic ImmunoEngineering reported asset growth of -89.95% for the quarter ended Mar 2026. These growth metrics cover 61 quarters of results from Nov 2010 through Mar 2026, standardized by Business Quant from the company’s SEC filings.

Growth MetricsGrowth Nov2010 Feb2011 May2011 Aug2011 Nov2011 Feb2012 May2012 Aug2012 Nov2012 Feb2013 May2013 Aug2013 Nov2013 Feb2014 May2014 Aug2014 Nov2014 Feb2015 May2015 Aug2015 Nov2015 Feb2016 May2016 Aug2016 Nov2016 Feb2017 May2017 Aug2017 Nov2017 Feb2018 May2018 Aug2018 Nov2018 Feb2019 May2019 Aug2019 Nov2019 Feb2020 May2020 Aug2020 Nov2020 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Growth Ratios
Assets Growth (1y)
50.86%-62.95%-2.86%-3.05%-63.21%65.52%-34.05%-31.29%-46.82%-96.68%-86.01%-21.12%23.85%369.98%38.42%-85.96%-89.95%
Assets Growth (3y)
-33.42%-72.68%-55.25%-19.30%-37.66%-36.29%-49.64%-57.62%-59.55%
Assets Growth (5y)
-48.36%
Assets (QoQ)
125.14%-26.01%-39.53%49.76%-44.71%94.01%-39.65%-43.18%148.78%-22.70%-37.12%-56.02%-84.45%225.41%254.47%-30.95%-40.99%-4.16%-64.05%-50.57%
Capital Expenditures Growth (1y)Capex Growth (1y)
Capital Expenditures Growth (3y)Capex Growth (3y)
Capital Expenditures Growth (5y)Capex Growth (5y)
Capital Expenditures (QoQ)Capex (QoQ)
Cash & Equivalents Growth (1y)Cash & Equiv. Growth (1y)
80.03%-64.62%-2.29%-2.43%-66.73%76.20%-34.16%-29.22%-48.29%-98.97%-97.73%-26.35%32.12%1,335.00%453.71%-96.85%-99.92%
Cash & Equivalents Growth (3y)Cash & Equiv. Growth (3y)
-32.34%-81.42%-75.56%-20.18%-38.97%-36.17%-56.44%-74.59%-91.70%
Cash & Equivalents Growth (5y)Cash & Equiv. Growth (5y)
-79.72%
Cash & Equivalents (QoQ)Cash & Equiv. (QoQ)
177.29%-32.49%-42.48%67.18%-45.51%86.48%-42.56%-43.00%188.58%-30.33%-38.24%-58.36%-94.26%53.62%1,905.21%-25.29%-37.64%-40.73%-88.60%-98.01%
Cash from Investing Activities Growth (1y)Cash from Investing Growth (1y)
Cash from Investing Activities Growth (3y)Cash from Investing Growth (3y)
Cash from Investing Activities Growth (5y)Cash from Investing Growth (5y)
Cash from Investing Activities (QoQ)Cash from Investing (QoQ)
362.34%
Cash from Operations Growth (1y)Cash from Ops. Growth (1y)
-11.35%-12.68%12.86%2.09%9.41%30.95%33.23%40.84%46.97%2.11%88.19%78.58%68.08%72.19%-67.89%-35.83%87.80%
Cash from Operations Growth (3y)Cash from Ops. Growth (3y)
18.82%8.68%59.04%50.12%46.48%42.71%49.04%44.37%72.56%
Cash from Operations Growth (5y)Cash from Ops. Growth (5y)
53.89%
Cash from Operations (QoQ)Cash from Ops. (QoQ)
10.37%-23.89%11.74%-13.62%9.31%4.19%0.83%-5.12%30.87%7.35%12.13%5.77%-27.61%88.82%-59.39%-40.41%-11.20%32.54%-28.95%87.38%
EBITDA Margin Growth (1y)
EBITDA Margin (QoQ)
EBIT Growth (1y)
9.37%9.77%46.18%39.69%36.93%60.11%39.70%44.61%41.54%22.19%40.22%45.52%34.97%45.73%22.57%1.35%11.43%
EBIT Growth (3y)
30.61%34.57%42.11%43.33%37.88%44.77%34.65%33.23%30.43%
EBIT Growth (5y)
28.08%
EBIT Margin Growth (1y)
EBIT Margin (QoQ)
EBIT (QoQ)
-21.75%1.88%14.16%11.63%-21.22%41.47%3.80%7.59%23.33%11.53%11.62%2.49%-2.06%32.03%19.46%-16.39%14.83%3.02%-2.62%-4.50%
EBT Growth (1y)
5.09%5.33%85.34%37.18%48.05%102.12%-116.88%44.66%27.27%-1,597.64%43.97%49.03%37.15%42.25%11.44%-12.28%3.29%
EBT Growth (3y)
28.95%33.07%43.73%43.84%38.07%43.23%-2.48%31.84%23.82%
EBT Growth (5y)
26.26%
EBT Margin Growth (1y)
EBT Margin (QoQ)
EBT (QoQ)
-21.75%-7.00%18.86%10.21%-21.45%83.43%-247.60%25.74%104.94%-1,799.19%11.31%2.39%-1.81%36.43%19.33%-20.36%6.45%2.52%-2.28%-3.67%
EPS (Basic) Growth (1y)
31.68%5.25%85.36%41.72%47.74%102.11%-116.85%44.67%27.70%-1,597.64%43.97%48.22%37.15%41.43%11.44%-10.52%3.29%
EPS (Basic) Growth (3y)
36.33%33.11%43.76%44.93%38.08%43.02%-2.47%31.84%23.97%
EPS (Basic) Growth (5y)
30.96%
EPS (Basic) (QoQ)
12.19%-7.00%12.70%16.69%-21.76%83.47%-247.60%25.30%104.91%-1,799.19%11.31%2.39%-1.81%36.43%18.04%-18.48%5.12%3.88%-2.28%-3.67%
EPS (Diluted) Growth (1y)
31.68%5.25%85.36%41.72%47.74%101.78%-116.85%44.67%27.70%-1,873.44%43.97%48.22%37.15%41.43%11.44%-10.52%3.29%
EPS (Diluted) Growth (3y)
36.33%33.11%43.76%44.93%38.08%43.02%-2.47%31.84%23.97%
EPS (Diluted) Growth (5y)
30.96%
EPS (Diluted) (QoQ)
12.19%-7.00%12.70%16.69%-21.76%83.47%-247.60%25.30%104.15%-2,112.12%11.31%2.39%-1.81%36.43%18.04%-18.48%5.12%3.88%-2.28%-3.67%
FCF Margin Growth (1y)
FCF Margin (QoQ)
Free Cash Flow Growth (1y)FCF Growth (1y)
-11.35%-12.68%12.86%2.09%9.41%30.95%33.23%40.84%46.97%2.11%88.19%78.58%68.08%72.19%-67.89%-35.83%87.80%
Free Cash Flow Growth (3y)FCF Growth (3y)
18.82%8.68%59.04%50.12%46.48%42.71%49.04%44.37%72.56%
Free Cash Flow Growth (5y)FCF Growth (5y)
53.89%
Free Cash Flow (QoQ)FCF (QoQ)
10.37%-23.89%11.74%-13.62%9.31%4.19%0.83%-5.12%30.87%7.35%12.13%5.77%-27.61%88.82%-59.39%-40.41%-11.20%32.54%-28.95%87.38%
Gross Margin Growth (1y)
Gross Margin (QoQ)
Gross Profit Growth (1y)
Gross Profit (QoQ)
Interest Coverage Ratio Growth (1y)Interest Cover Growth (1y)
13.48%-17.55%11.46%
Interest Coverage Ratio (QoQ)Interest Cover (QoQ)
24.47%-41.79%15.75%4.10%-2.62%-6.79%
Net Cash Flow Growth (1y)NCF Growth (1y)
206.43%-146.22%194.16%2.09%-162.45%237.85%-161.79%40.84%3.93%-149.03%101.82%212.99%68.08%72.19%-1,190.01%-125.75%87.80%
Net Cash Flow Growth (3y)NCF Growth (3y)
13.89%-32.24%26.21%38.46%-29.89%42.71%-28.51%44.37%66.55%
Net Cash Flow Growth (5y)NCF Growth (5y)
52.23%
Net Cash Flow (QoQ)NCF (QoQ)
360.83%-150.81%11.74%190.98%-213.26%203.53%-191.78%41.97%350.02%-146.41%12.13%5.77%-27.61%101.72%5,358.69%-126.62%-11.20%32.54%-28.95%87.38%
Net Income Growth (1y)
5.37%5.08%85.34%37.18%47.73%102.11%-116.88%44.66%27.70%-1,597.64%43.97%48.22%37.15%41.43%11.44%-10.52%3.29%
Net Income Growth (3y)
29.02%33.07%43.73%43.54%38.07%43.01%-2.48%31.84%23.97%
Net Income Growth (5y)
26.31%
Net Income (QoQ)
-21.39%-7.00%18.86%10.21%-21.76%83.47%-247.60%25.29%104.91%-1,799.19%11.31%2.39%-1.81%36.43%18.04%-18.48%5.12%3.88%-2.28%-3.67%
Net Income towards Common Stockholders Growth (1y)Net Income Growth (1y)
5.37%5.08%85.34%37.18%47.73%102.11%-116.88%44.66%27.70%-1,597.64%43.97%48.22%37.15%41.43%11.44%-10.52%3.29%
Net Income towards Common Stockholders Growth (3y)Net Income Growth (3y)
29.02%33.07%43.73%43.54%38.07%43.01%-2.48%31.84%23.97%
Net Income towards Common Stockholders Growth (5y)Net Income Growth (5y)
26.31%
Net Income towards Common Stockholders (QoQ)Net Income (QoQ)
-21.39%-7.00%18.86%10.21%-21.76%83.47%-247.60%25.29%104.91%-1,799.19%11.31%2.39%-1.81%36.43%18.04%-18.48%5.12%3.88%-2.28%-3.67%
Net Margin Growth (1y)
Net Margin (QoQ)
Operating Income Growth (1y)Op. Inc Growth (1y)
46.18%39.69%36.93%60.11%39.70%44.61%41.54%22.19%40.22%45.52%34.97%45.73%22.57%1.35%11.43%
Operating Income Growth (3y)Op. Inc Growth (3y)
42.11%43.33%37.88%44.77%34.65%33.23%30.43%
Operating Income (QoQ)Op. Inc (QoQ)
14.16%11.63%-21.22%41.47%3.80%7.59%23.33%11.53%11.62%2.49%-2.06%32.03%19.46%-16.39%14.83%3.02%-2.62%-4.50%
Operating Margin Growth (1y)
Operating Margin (QoQ)
Profit After Tax Growth (1y)PAT Growth (1y)
5.37%5.08%85.34%37.18%47.73%102.11%-116.88%44.66%27.70%-1,597.64%43.97%48.22%37.15%41.43%11.44%-10.52%3.29%
Profit After Tax Growth (3y)PAT Growth (3y)
29.02%33.07%43.73%43.54%38.07%43.01%-2.48%31.84%23.97%
Profit After Tax Growth (5y)PAT Growth (5y)
26.31%
Profit After Tax (QoQ)PAT (QoQ)
-21.39%-7.00%18.86%10.21%-21.76%83.47%-247.60%25.29%104.91%-1,799.19%11.31%2.39%-1.81%36.43%18.04%-18.48%5.12%3.88%-2.28%-3.67%
Property, Plant & Equipment (Net) Growth (1y)PP&E (Net) Growth (1y)
Property, Plant & Equipment (Net) Growth (3y)PP&E (Net) Growth (3y)
Property, Plant & Equipment (Net) Growth (5y)PP&E (Net) Growth (5y)
Property, Plant & Equipment (Net) (QoQ)PP&E (Net) (QoQ)
Return on Assets [ROA] Growth (1y)ROA Growth (1y)
-0.07M-0.06M-0.02M0.03M0.01M0.07M0.04M0.03M0.03M-0.22M-0.37M-0.06M0.00M0.18M0.29M-0.08M-0.39M
Return on Assets [ROA] Growth (3y)ROA Growth (3y)
-0.03M-0.21M-0.34M0.00M0.04M0.03M-0.04M-0.11M-0.36M
Return on Assets [ROA] Growth (5y)ROA Growth (5y)
-0.42M
Return on Assets [ROA] (QoQ)ROA (QoQ)
-0.02M-0.01M-0.04M-0.01M-0.01M0.03M0.01M-0.03M0.06M0.00M-0.01M-0.03M-0.20M-0.14M0.31M0.03M-0.02M-0.03M-0.06M-0.28M
Return on Capital Employed [ROCE] Growth (1y)ROCE Growth (1y)
Return on Capital Employed [ROCE] Growth (3y)ROCE Growth (3y)
Return on Capital Employed [ROCE] Growth (5y)ROCE Growth (5y)
Return on Capital Employed [ROCE] (QoQ)ROCE (QoQ)
Return on Equity [ROE] Growth (1y)ROE Growth (1y)
Return on Equity [ROE] Growth (3y)ROE Growth (3y)
Return on Equity [ROE] Growth (5y)ROE Growth (5y)
Return on Equity [ROE] (QoQ)ROE (QoQ)
Return on Sales [ROS] Growth (1y)ROS Growth (1y)
Return on Sales [ROS] (QoQ)ROS (QoQ)
Revenue Growth (1y)
Revenue (QoQ)
Share-based Compensation Growth (1y)Stock Comp. Growth (1y)
-49.31%-76.71%-85.67%-97.42%-96.11%-94.42%-89.28%-15.32%-10.00%
Share-based Compensation Growth (3y)Stock Comp. Growth (3y)
-73.92%
Share-based Compensation (QoQ)Stock Comp. (QoQ)
53.43%-14.45%-29.72%-45.06%-29.50%-47.35%-87.34%-17.17%1.13%1.10%0.00%-11.97%
Tax Rate Growth (1y)
Total Debt Growth (1y)
256.30%170.45%0.00%0.00%
Total Debt (QoQ)
31.74%170.45%0.00%0.00%0.00%0.00%0.00%

Mosaic ImmunoEngineering Growth Metrics API

Pull Mosaic ImmunoEngineering's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=CPMV&statement=Growth&frequency=Quarter&period=all&api_key=YOUR_API_KEY